z-logo
open-access-imgOpen Access
Sleep‐based therapy: A new treatment for amyotrophic lateral sclerosis
Author(s) -
Qing Cai,
Mengya Li,
Qifang Li
Publication year - 2021
Publication title -
brain science advances
Language(s) - English
Resource type - Journals
ISSN - 2096-5958
DOI - 10.26599/bsa.2021.9050010
Subject(s) - amyotrophic lateral sclerosis , medicine , neuroprotection , sleep (system call) , neuroscience , pathogenesis , pathological , mechanism (biology) , disease , pathology , psychology , philosophy , epistemology , computer science , operating system
Amyotrophic lateral sclerosis (ALS) is a worldwide problem with no effective treatment. Patients usually die of respiratory failure. The basic pathological process of ALS is the degeneration and necrosis of motor neurons. Neuroglial cell dysfunction is considered closely related to the development of ALS. Sleep plays an important role in repairing the nervous system, and sleep disorders can worsen ALS. Herein, we review the pathogenesis of ALS and the neuroprotective mechanism of sleep‐based therapy. Sleep‐based therapy could be a potential strategy to treat ALS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom